Analytical Data
-
基因名
deacetylase
- Application
-
别名
Chitin deacetylase; EC 3.5.1.41
-
种属
Amylomyces rouxii
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P50325
-
表达区间
22-421aa
-
分子量
49.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Deacetylases are a class of enzymes that play a critical role in various biological processes by removing acetyl groups from lysine residues on proteins, thereby influencing their function, stability, and interactions. The study of deacetylases, particularly in the context of recombinant protein research, has gained significant attention due to their essential roles in cellular regulation, gene expression, and metabolism. Deacetylases, such as histone deacetylases (HDACs), are involved in epigenetic regulation, impacting gene transcription and influencing processes like cell differentiation and apoptosis. The disruption of deacetylase activity has been linked to various diseases, including cancer, neurodegenerative disorders, and metabolic syndromes, highlighting their potential as therapeutic targets. The recombinant expression of deacetylases allows for detailed biochemical characterization and functional analysis, enabling researchers to understand their mechanisms and explore their applications in disease treatment. Advances in molecular biology techniques, such as CRISPR and protein engineering, further facilitate the study of deacetylases, providing insights into their structure-function relationship and opening new avenues for drug development. Understanding the intricate roles of deacetylases through recombinant protein studies not only enhances our comprehension of fundamental biological processes but also paves the way for innovative therapeutic strategies aimed at manipulating their activity for disease intervention.












